SCHEMBL8523300

SCHEMBL8523300

CCCCCNc1ncnc2c1c(CCCCC)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O

nearest known ligand 0.61

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 18/20 0.61
▸ SLC29A1 Q99808 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8523347 0.89 SLC29A1 (0.67) ADKSLC29A1
SCHEMBL8466994 0.87 ADK (0.62) ADKSLC29A1
SCHEMBL8461010 0.87 ADK (0.68) ADKSLC29A1
SCHEMBL8464085 0.76 ADK (0.73) ADKSLC29A1
SCHEMBL8469111 0.76 SLC29A1 (0.68) ADKSLC29A1
SCHEMBL4623566 0.69 LMNA (0.69) ADKSLC29A1
SCHEMBL4623569 0.69 LMNA (0.69) ADKSLC29A1
SCHEMBL6758644 0.67 SLC29A1 (0.98) SLC29A1
SCHEMBL31628603 0.67 SLC29A1 (0.98) SLC29A1
SCHEMBL8328951 0.67 SLC29A1 (0.98) SLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0496617-B1 Adenosine kinase inhibitors METABASIS THERAPEUTICS INC (US) 1999-12-01 — — EP disclosed
US-5646128-A TREATING INFLAMMATION, SEPSIS, SEPTIC SHOCK, BURNS GENSIA, INC. (US) 1997-07-08 — — US disclosed
EP-0496617-A1 Adenosine kinase inhibitors GENSIA, INC. (US) 1992-07-29 — — EP disclosed
Send feedback